MyoPro-Assisted Therapy for Stroke
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if the MyoPro, a special wearable device, improves arm movement in individuals who had a stroke over six months ago. Participants will either use the MyoPro with motor learning therapy or receive the therapy alone to assess which approach is more effective. The trial also examines potential brain changes in response to treatment and evaluates the cost-effectiveness of the MyoPro. Individuals who have experienced a stroke, suffer from severe arm weakness, and can generate detectable muscle signals might be suitable candidates for this trial. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance stroke recovery therapies.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you are taking medications that lower the threshold for seizures, you may not be eligible to participate.
What prior data suggests that the MyoPro device is safe for use in stroke therapy?
Research has shown that the FDA has approved the MyoPro device as a Class II medical device, indicating it meets specific safety standards. However, limited research exists on its long-term safety or effectiveness. The device assists people with weak or paralyzed arms by using muscle signals to aid movement. Although it appears promising for some users, the absence of detailed studies means potential side effects remain unknown. Always consult a healthcare provider when considering new treatments.12345
Why are researchers excited about this trial?
Researchers are excited about MyoPro-assisted therapy for stroke rehabilitation because it uniquely combines advanced robotics with motor learning principles. Unlike traditional physical therapy, which often relies on repetitive exercises, MyoPro pairs a wearable robotic device with therapy to enhance the brain's ability to rewire and improve motor function. This innovative approach not only supports the affected limb but also actively engages it, potentially leading to more significant recovery outcomes. By integrating technology with therapy, this method offers hope for faster and more effective stroke recovery, setting it apart from existing treatments.
What evidence suggests that the MyoPro device is effective for stroke rehabilitation?
Research shows that the MyoPro device can help stroke survivors improve arm movement. In this trial, one group of participants will receive MyoPro paired with motor learning-based therapy, while another group will receive only motor learning-based therapy. Earlier studies found that patients using MyoPro had better control over their movements and could perform more everyday tasks with their affected arm. The device detects weak muscle signals and assists with movement, making arm use easier. Studies have also found that wearing the MyoPro can reduce arm movement difficulties, aiding recovery after a stroke. Overall, therapy with MyoPro shows promising results for those with severe arm movement issues post-stroke.13678
Who Is on the Research Team?
Svetlana Pundik, MD
Principal Investigator
Louis Stokes VA Medical Center, Cleveland, OH
Are You a Good Fit for This Trial?
Adults aged 18-89 with severe arm weakness from a stroke that happened at least 6 months ago can join. They must be able to move their shoulder a bit, wear the MyoPro device, and produce muscle signals it can read. People with metal in their skull, pacemakers, or conditions like seizures or claustrophobia that make MRI scans unsafe cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 9 weeks of in-clinic training with MyoPro and motor learning-based therapy, followed by 9 weeks of home practice
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Motor Learning-Based Therapy
- MyoPro
Motor Learning-Based Therapy is already approved in United States, European Union for the following indications:
- Severe chronic arm motor deficits due to stroke
- Neuromuscular rehabilitation for conditions such as stroke, spinal cord injury, and brachial plexus injury
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor